CCND1 and serous adenocarcinoma: Weak cyclin D1 staining was observed in high‐grade serous carcinoma (P < .001), lymphatic vascular invasion (P = .026), bilateral involvement (P < .001), necrosis (P = .004), and patients with recurrence (P = .006).